hVIVO (LON:HVO) Trading 9.9% Higher – What’s Next?

Shares of hVIVO plc (LON:HVO) were up 9.9% during trading on Monday . The stock traded as high as GBX 21.50 ($0.27) and last traded at GBX 21.24 ($0.26). Approximately 2,611,591 shares were traded during mid-day trading, a decline of 2% from the average daily volume of 2,672,759 shares. The stock had previously closed at GBX 19.33 ($0.24).

hVIVO Stock Performance

The company has a market cap of £144.24 million, a PE ratio of 706.67 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The stock’s 50-day simple moving average is GBX 20.36 and its 200 day simple moving average is GBX 25.73.

About hVIVO

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.